Results 1 - 25 from 147 for "antibiotice"
-
Antibiotice Iasi To Supply 7 million Vials Of Injectable Antibiotics To Hospitals In the UK Over Next Two Years
06.05.2025
State-owned pharmaceutical producer Antibiotice Iasi (ATB.RO) has announced in a stock market report on June 5 that it recently won the 5th tender organized by the National Health Service (NHS), the more
-
Antibiotice Iasi Q1/2025 Revenues Down 6% To RON180M; Net Profit Falls 13% To RON32.6M
05.14.2025
Pharma producer Antibiotice Iasi in the first quarter of this year generated total revenues of RON180 million, down 6%, and net profit of RON32.6 million, 13% lower than the year-earlier level. more
-
Antibiotice Considers Issuing Bonds On Capital Market
03.17.2025
Pharmaceutical producer Antibiotice Iasi (ATB.RO), is considering issuing bonds on the Bucharest Stock Exchange to raise cash to develop the business, said Liviu Vatavu, Antibiotice executive more
-
Antibiotice Iasi Wants to Distribute RON13.8M Worth of Dividends
03.13.2025
Romanian drug manufacturer Antibiotice Iasi has proposed the distribution of RON13.8 million worth of dividends from the 2024 net profit reported on the basis of annual audited financial statements, more
-
IBM Research Delegation Visits Antibiotice Iasi Plant
03.07.2025
Officials of the research division of US’ IBM, IBM Research, have visited the pharmaceutical plant of Antibiotice Iasi (ATB.RO), the largest Romanian-held pharmaceutical producer, to discuss more
-
Antibiotice Iasi 2024 Revenues Up 8% To RON693M, Net Profit Rises 23% To RON99M
02.26.2025
Romanian drug manufacturer Antibiotice Iasi in 2024 registered total revenues worth RON693 million, up 8%, and RON99 million net profit, 23% above the 2023 level. more
-
Pension Funds Bought Into Antibiotice Iasi Following Sale Of Part Of Infinity Capital Stake
01.13.2025
BCR Pensii and BRD Pensii, Pillar II private pension funds, which manage pensions for 1.4 million people, bought into pharmaceutical producer Antibiotice Iasi (ATB.RO), spending RON50 million during more
-
Antibiotice Iasi Ends Jan-Sept 2024 with RON511M Revenues, Up 7%. Net Profit Rises 15% To RON88M
11.15.2024
Romanian drug manufacturer Antibiotice Iasi, in which the Romanian state hold 53%, registered RON511 million revenues in the first nine months of 2024, up 15% annually, while net profit went up by 15% more
-
Antibiotice Iasi Aims to Invest RON850M by 2030
10.02.2024
Romanian drug manufacturer Antibiotice Iasi has a RON850 million investment plan until 2030, covered through a funding mix, made up of cohesion funds, state aid, PNRR funds and EIB loan, stated more
-
BET Index Of Bucharest Stock Exchange Includes Antibiotice And Premier Energy As Of Sept 23
09.23.2024
The BET index, the main index of the Bucharest Stock Exchange (BVB), is welcoming two new companies: Antibiotice Iasi (ATB) and Premier Energy (PE), starting September 23, 2024. more
-
Antibiotice Iasi Export Revenue Doubles In H1 2024 Vs H1 2020
08.21.2024
Antibiotice Iasi (ATB.RO), the largest Romanian-held drug producer, posted RON150 million revenue from exports in the first half of 2024, an increase of 25% on the year-ago period. more
-
Antibiotice Iasi Reports RON74M Net Profit For H1/2024, Up 20% YoY
08.14.2024
Romanian-owned drug manufacturer Antibiotice Iasi (stock symbol: ATB) ended the first half of 2024 with net profit of RON74 million, up 20% on the year, while its revenue rose by 8% to RON380 million, more
-
Romanian-Held Pharmaceutical Manufacturer Antibiotice To Get EUR100M In EU Funding To Make Critical Drugs
06.06.2024
Antibiotice Iasi, (ATB.RO) the largest Romanian-owned pharmaceutical producer, will receive EUR100 million in EU funding for the production of drugs such as antibiotics, for which there are no more
-
Antibiotice Iasi Records 13% Revenue Growth in Q1/2024. Net Profit Climbs 68%
05.15.2024
Antibiotice Iasi, the largest Romanian-owned drug manufacturer, saw revenues reach an overall RON192.5 million level, 13% higher than in the year-earlier period. more
-
Antibiotice Iasi Eyes RON850M Investments by 2030
04.30.2024
Antibiotice Iasi, the largest Romanian-held drug maker, has a total RON850 million investment plan between 2023-2030 to reach RON1 billion turnover at the end of this period. more
-
Antibiotice Iasi Commissions 2.5 MW Photovoltaic Plant
03.28.2024
Pharma manufacturer Antibiotice Iasi has commissioned a 2.5 MW photovoltaic plant, with total investments in the project amounting to RON11.8 million, of which RON4.07 million were granted by the more
-
Antibiotice Iasi Wants to Cross RON100M Profit Threshold in 2024
03.25.2024
Antibiotice Iasi, the biggest Romanian-held drug manufacturer, wants to reach RON104 million net profit in 2024, up 28% from 2023, in line with its income and expenses budget. more
-
Antibiotice Iasi Seeks To Pay Dividends Of RON31M From 2023 Profit
03.14.2024
Pharmaceutical manufacturer Antibiotice Iasi (ATB.RO) is summoning its shareholders to approve, among others, the distribution of RON31 million from the company's 2023 profit under the form of more
-
Antibiotice Iasi's Net Profit More Than Doubles YoY To RON80.7M In 2023
02.28.2024
Pharmaceutical manufacturer Antibiotice Iasi (ATB.RO) ended 2023 with net profit of RON80.7 million, up 109.5% from 2022, and a turnover of RON600.8 million, up 7.2% on the year, in line with more
-
Antibiotice Iasi Launches New Vet Product Range
02.09.2024
Antibiotice Iasi, the largest Romanian-held pharma producer, is launching eight veterinary products in the range of nutritional supplements, complementing the company’s veterinary prescription more
-
Antibiotice Iasi Calls Shareholders To Approve Contracting RON35M Credit Facility From Banca Transilvania
01.25.2024
The Board of Directors of pharmaceutical manufacturer Antibiotice Iasi (ATB.RO) announced in a stock market report on Thursday (Jan. 25, 2024) that it has called shareholders for a meeting on February more
-
Antibiotice Iasi Shares To Be Included In MSCI Indices Starting With 1st Trading Day Of Dec 2023
11.16.2023
The Bucharest Stock Exchange has announced Wednesday evening that the shares of Antibiotice (ATB.RO), the Romanian manufacturer of generic drugs, listed on the local capital market for 26 years, will more
-
Antibiotice Iasi Ends 9M 2023 with RON463.4M Turnover, Up 28%, RON76M Net Profit, More than Double the 9M 2022 Level
11.15.2023
Romanian state-owned pharma producer Antibiotice Iasi for the first nine months of 2023 reported RON463.4 million turnover, up 28%, and RON76 million net profit, more than doubled the RON30 million more
-
First Loan Via InvestEU In Romania Goes To Antibiotice Iasi For New Plant
11.10.2023
Pharmaceutical manufacturer Antibiotice Iasi (ATB.RO) has signed a EUR25 million loan agreement with the European Investment Bank (EIB), which will help finance the construction of new production more
-
Antibiotice Iasi Shareholders OK EUR25M Funding from EIB
10.31.2023
The extraordinary general meeting of shareholders convened by drug maker Antibiotice Iasi on October 30 approved the signing of a financing contract worth EUR25 million euro, i.e. RON23 million more